Financials
Financial year 2025
NIPRO MEDICAL EUROPE from Mechelen, company number BE0444276727, closed financial year 2025 with a result of € -3.1 million after tax. For that financial year NIPRO MEDICAL EUROPE recorded revenue of € 385.9 million and equity of € 78.2 million. Compared with financial year 2024, the result moved from € 8.9 million to € -3.1 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 78.2 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3.1 million
▼ still € 8.9 million profit in 2024
Profit after tax over the fiscal year.
€ 199,593
▼ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -6.2 million.
People and assets in 2025
89.6
▲ 10.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 10.4 million
▲ 4% vs 2024
€ 115,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 113,595
▲ 14% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 49 million
▼ 4% vs 2024
Loans from banks and other lenders, long and short.
€ 158.6 million
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 158 days on average.
€ 2.9 million
▼ 8% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 286,378,745 | € 333,603,629 | € 361,116,776 | € 385,885,256 | ▲ 7% |
| Profit after taxes | € 3,307,575 | € 11,612,615 | € 8,867,746 | € -3,052,888 | ▼ € 11.9 million |
| Equity | € 60,754,292 | € 72,366,906 | € 81,234,653 | € 78,181,764 | ▼ 4% |
| Total debts | € 238,601,098 | € 231,992,790 | € 260,665,993 | € 244,357,598 | ▼ 6% |
| Cash | € 3,334,879 | € 2,864,339 | € 560,476 | € 199,593 | ▼ 64% |
| Retained profit | € -23,608,983 | € -11,996,368 | € -3,128,622 | € -6,181,511 | ▼ € 3.1 million |
| Bank debt | € 56,398,304 | € 51,000,000 | € 51,000,000 | € 49,000,000 | ▼ 4% |
| Balance sheet total | € 299,927,123 | € 305,005,429 | € 342,517,008 | € 324,746,850 | ▼ 5% |
| Employees (FTE) | 64.6 | 71.5 | 79 | 89.6 | ▲ 10.6 |
Key figures of NIPRO MEDICAL EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NIPRO MEDICAL EUROPE?
What happened at NIPRO MEDICAL EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Sensus Strategies stepped down as director. NBB
- Goichi MIYAZUMI stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.1 million (▼ € 11.9 million vs 2024). Source: NBB ↗
- Sensus Strategies became a director. NBB
- Goichi MIYAZUMI became a director. NBB
- New establishment in Mechelen. KBO
- Start of the company according to the CBE. KBO
In short
From € 3.3 million profit in 2022 to € 3.1 million loss in 2025.
Paid € 11 million in corporate taxes since 2022.
Best year ever: 2023, with € 11.6 million profit.
Pays suppliers within 158 days on average.
A new publication or filing at NIPRO MEDICAL EUROPE? We notify you, reason included.
Follow NIPRO MEDICAL EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Nipro Europe Group Companies NV (100%). It owns 100% of Nipro Medical Cameroon SARL, 100% of Nipro Medical Kenya Limited , 100% of Nipro Diagnostics Germany GmbH , 100% of Nipro Medical South Africa (PTY) LT , 100% of Nipro Medical Italy SRL and 100% of Nipro Senegal SUARL itself.
Directors
According to the 2025 annual accounts
since 2025 · until 2030
since 2024 · until 2030
Shareholders
Participations
Nipro Medical Cameroon SARL
100%
Nipro Medical Kenya Limited
100%
Nipro Diagnostics Germany GmbH
100%
Nipro Medical South Africa (PTY) LT
100%
Nipro Medical Italy SRL
100%
Nipro Senegal SUARL
100%
Nipro Medical Poland Sp. z o.o.
100%
OOO Nipro Medical
100%
Nipro Medical Spain, S.L.U
100%
Nipro MIC Technical Services GmbH
100%
URC SOUTH AFRICA (PTY) LTD
100%
Nipro Renal Solutions Spain, S.L.
100%
Nipro Pure Water GmbH
100%
Nipro Médical France
100%
Nipro Medical Morocco SARLAU
100%
Nipro Nordics AB
100%
Nipro Medical UK LTD
100%
Nipro Medical Ivory Coast
100%
Nipro Medical DOO Beograd
100%
NIPRO MEDIKAL SAG. HIZ. TIC. LTD. S
100%
Nipro Medical Germany GmbH
100%
Nipro Medical Austria GmbH
100%
Nipro Diagnostics UK Limited
100%
MTN Neubrandenburg GmbH
100%
Nipro Medical Nigeria
100%
Establishments
Establishment units
Physical locations of this company
Blokhuisstraat 42
2800 Mechelen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0444.276.727
- VAT number
- BE 0444.276.727
- Registered office
- Blokhuisstraat 42, 2800 Mechelen
- Names & denominations
- NIPRO MEDICAL EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 May 1991
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen